- Business
- CompuGroup Medical SE & Co. KGaA develops and provides e-health software solutions supporting medical and organizational activities in physicians' practices, pharmacies, laboratories, hospitals, and care facilities worldwide; its core offerings span Ambulatory Information Systems (AIS) including practice management software for registered physicians, medical care centers, and physician networks covering clinical, administrative, and billing functions; Pharmacy Information Systems (PCS) with integrated administrative, billing, and supply chain applications for medication procurement, inventory management, and retail operations; Hospital Information Systems (HIS) delivering clinical and administrative solutions for inpatient care such as admission, medication, surgery, and discharge processes; additional products encompass laboratory information systems, electronic health records, drug information systems, web-based patient files, medical archiving, referring physician portals, revenue cycle management services, EDI clearinghouse capabilities, AI-powered tools for faxes and scans, and cloud-based connectivity solutions. The company, founded in 1987 by Frank Gotthardt and headquartered in Koblenz, Germany, operates in over 60 countries across Europe, North America, Asia, Africa, and beyond with more than 8,700 employees serving over 1.6 million users including doctors, dentists, pharmacists, insurers, and inpatient/outpatient facilities. In recent developments, CompuGroup Medical entered a strategic partnership with CVC Capital Partners in December 2024, culminating in CVC's acquisition of a approximately 28% stake, the company's delisting from public exchanges in June 2025 while the founding family retains majority control, and the acquisition of Norwegian firm Pridok in 2024 to bolster its Northern European market position in interoperability solutions; further enhancements include expanded AI and cloud-based products, leadership transition with Prof. Dr. Daniel Gotthardt as CEO since September 2024, and significant adoption in electronic prescriptions handling 30% of Germany's GP e-prescriptions post-2024 nationwide rollout.